Agency Information Collection Activities: Proposed Collection; Comment Request, 27144-27146 [2019-12291]
Download as PDF
<![CDATA[
khammond on DSKBBV9HB2PROD with NOTICES
27144
Federal Register / Vol. 84, No. 112 / Tuesday, June 11, 2019 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interdisciplinary Molecular Sciences
Training Member Conflict.
Date: July 2, 2019.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL II,
6701 Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B,
MSC 7892, Bethesda, MD 20892, 301–408–
9655, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
19–018: Clinical Trials Development for CoOccurring Conditions in Individuals with
Down Syndrome: Phased Awards for
INCLUDE (R61/R33).
Date: July 8, 2019.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Maribeth Champoux,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: July 9, 2019.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL II,
6701 Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Juraj Bies, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Rm. 4158, MSC 7806, Bethesda, MD
20892, 301–435–1256, biesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Dated: June 5, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–12222 Filed 6–10–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:36 Jun 10, 2019
Jkt 247001
Substance Abuse and Mental Health
Services Administration
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1112.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Opioid Drugs in
Maintenance and Detoxification
Treatment of Opioid Dependence—42
CFR Part 8 (OMB No. 0930–0206) and
Opioid Treatment Programs (OTPs)—
Extension
42 CFR part 8 establishes a
certification program managed by
SAMHSA’s Center for Substance Abuse
Treatment (CSAT). The regulation
requires that Opioid Treatment
Programs (OTPs) be certified.
‘‘Certification’’ is the process by which
SAMHSA determines that an OTP is
qualified to provide opioid treatment
under the Federal opioid treatment
standards established by the Secretary
of Health and Human Services. To
become certified, an OTP must be
accredited by a SAMHSA-approved
accreditation body. The regulation also
provides standards for such services as
individualized treatment planning,
increased medical supervision, and
assessment of patient outcomes. This
submission seeks continued approval of
the information collection requirements
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
in the regulation and of the forms used
in implementing the regulation.
SAMHSA currently has approval for
the Application for Certification to Use
Opioid Drugs in a Treatment Program
Under 42 CFR 8.11 (Form SMA–162);
the Application for Approval as
Accreditation Body Under 42 CFR 8.3(b)
(Form SMA–163); and the Exception
Request and Record of Justification
Under 42 CFR 8.12 (Form SMA–168),
which may be used on a voluntary basis
by physicians when there is a patient
care situation in which the physician
must make a treatment decision that
differs from the treatment regimen
required by the regulation. Form SMA–
168 is a simplified, standardized form to
facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the
recordkeeping requirements in the
regulation are customary and usual
practices within the medical and
rehabilitative communities and has not
calculated a response burden for them.
The recordkeeping requirements set
forth in 42 CFR 8.4, 8.11 and 8.12
include maintenance of the following: 5year retention by accreditation bodies of
certain records pertaining to
accreditation; documentation by an OTP
of the following: A patient’s medical
examination when admitted to
treatment, A patient’s history, a
treatment plan, any prenatal support
provided the patient, justification of
unusually large initial doses, changes in
a patient’s dosage schedule, justification
of unusually large daily doses, the
rationale for decreasing a patient’s clinic
attendance, and documentation of
physiologic dependence.
The rule also includes requirements
that OTPs and accreditation
organizations disclose information. For
example, 42 CFR 8.12(e)(1) requires that
a physician explain the facts concerning
the use of opioid drug treatment to each
patient. This type of disclosure is
considered to be consistent with the
common medical practice and is not
considered an additional burden.
Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations
shall make public their fee structure;
this type of disclosure is standard
business practice and is not considered
a burden.
The tables that follow summarize the
annual reporting burden associated with
the regulation, including burden
associated with the forms. There are no
changes being made to the forms.
E:\FR\FM\11JNN1.SGM
11JNN1
27145
Federal Register / Vol. 84, No. 112 / Tuesday, June 11, 2019 / Notices
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR ACCREDITATION BODIES
Number of
respondents
42 CFR citation
Purpose
8.3(b)(1–11) ........
8.3(c) ..................
8.3(e) ..................
8.3(f)(2) ...............
Initial approval (SMA–163) .................
Renewal of approval (SMA–163) ........
Relinquishment notification .................
Non-renewal notification to accredited
OTPs.
Notification to SAMHSA for seriously
noncompliant OTPs.
Notification to OTP for serious noncompliance.
General documents and information
to SAMHSA upon request.
Accreditation survey to SAMHSA
upon request.
List of surveys, surveyors to SAMHSA
upon request.
Report of less than full accreditation
to SAMHSA.
Summaries of Inspections ..................
Notifications of Complaints .................
Revocation notification to Accredited
OTPs.
Submission of 90-day corrective plan
to SAMHSA.
Notification to accredited OTPs of
Probationary Status.
8.4(b)(1)(ii) ..........
8.4(b)(1)(iii) .........
8.4(d)(1) ..............
8.4(d)(2) ..............
8.4(d)(3) ..............
8.4(d)(4) ..............
8.4(d)(5) ..............
8.4(e) ..................
8.6(a)(2) and
(b)(3).
8.6(b) ..................
8.6(b)(1) ..............
Subtotal .......
.............................................................
Responses/
respondent
Total
responses
Hours/
response
Total hours
1
2
1
1
1
1
1
90
1
2
1
90
6.0
1.0
0.5
0.1
6
2
0.5
9
2
2
4
1.0
4
2
10
20
1.0
20
6
5
30
0.5
15
6
75
450
0.02
9
6
6
36
0.2
7.2
6
5
30
0.5
15
6
12
1
50
6
185
300
72
185
0.5
0.5
0.3
150
36
55.5
1
1
1
10
10.0
1
185
185
0.3
55.0
54
........................
1,407
........................
394.20
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR OPIOID TREATMENT PROGRAMS
Purpose
8.11(b) ................
8.11(b) ................
8.11(e)(1) ............
8.11(e)(2) ............
Renewal of approval (SMA–162) ........
Relocation of Program (SMA–162) .....
Application for provisional certification
Application for extension of provisional certification.
Notification of sponsor or medical director change (SMA–162).
Documentation to SAMHSA for interim maintenance.
Request to SAMHSA for Exemption
from 8.11 and 8.12 (including
SMA–168).
Notification to SAMHSA Before Establishing Medication Units (SMA–162).
Notification to State Health Officer
When Patient Begins Interim Maintenance.
Contents of Appellant Request for Review of Suspension.
Informal Review Request ....................
Appellant’s Review File and Written
Statement.
Appellant’s Request for Expedited Review.
Appellant Review File and Written
Statement.
8.11(f)(5) .............
8.11(g)(2) ............
8.11(h) ................
8.11(i)(1) .............
8.12(j)(2) .............
8.24 .....................
8.25(a) ................
8.26(a) ................
8.28(a) ................
khammond on DSKBBV9HB2PROD with NOTICES
Number of
respondents
42 CFR citation
8.28(c) ................
Responses/
respondent
Total
responses
Hours/
response
Total hours
386
35
42
30
1
1
1
1
386
35
42
30
0.15
1.17
1
0.25
57.9
40.95
42.00
7.50
60
1
60
0.1
6.00
1
1
1
1
1.00
1,200
20
24,000
0.07
1,680
10
1
10
0.25
2.5
1
20
20
0.33
6.6
2
1
2
0.25
.50
2
2
1
1
2
2
1.00
5.00
2.00
10.00
2
1
2
1.00
2.00
2
1
2
5.00
10.00
Subtotal .......
.............................................................
1,775
........................
24,594
........................
1868.95
Total .....
.............................................................
1,829
........................
26,001
........................
2,263.15
VerDate Sep<11>2014
17:36 Jun 10, 2019
Jkt 247001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\11JNN1.SGM
11JNN1
27146
Federal Register / Vol. 84, No. 112 / Tuesday, June 11, 2019 / Notices
Send comments to Janet Heekin,
SAMHSA Reports Clearance Officer,
Room 15E21–B, 5600 Fishers Lane,
Rockville, MD 20850 OR email her a
copy at janet.heekin@samhsa.hhs.gov.
Written comments should be received
within 60 days of this notice.
Dated: June 6, 2019.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2019–12291 Filed 6–10–19; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
khammond on DSKBBV9HB2PROD with NOTICES
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1112.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Protection and
Advocacy for Individuals With Mental
Illness (PAIMI) Final Rule, 42 CFR Part
51 (OMB No. 0930–0172)—Extension
These regulations meet the directive
under 42 U.S.C. 10826(b) requiring the
Secretary to promulgate final
regulations to carry out the PAIMI Act
(42 U.S.C. 10801 et seq.). The
regulations contain information
collection requirements associated with
the rule. The Act authorizes funds to
support activities on behalf of
individuals with significant (severe)
VerDate Sep<11>2014
17:36 Jun 10, 2019
Jkt 247001
mental illness (adults) or significant
(severe) emotional impairment
(children/youth) as defined by the Act
at 42 U.S.C. 10802(4) and 10804(d).
Only entities designated by the governor
of each State, including the American
Samoa, Guam, Commonwealth of the
Northern Mariana Islands,
Commonwealth of Puerto Rico, U.S.
Virgin Islands, District of Columbia
(Mayor), and the tribal councils of the
American Indian Consortium (the Hopi
Tribe and the Navajo Nation located in
the Four Corners region of the
Southwest), to protect and advocate the
rights of persons with developmental
disabilities are eligible to receive PAIMI
Program grants [ibid at 42 U.S.C. at
10802(2)]. These grants are based on a
formula prescribed by the Secretary
[ibid at 42 U.S.C. at 10822(a)(1)(A)].
On January 1, each eligible state
protection and advocacy (P&A) system
is required to prepare an annual PAIMI
Program Performance Report (PPR).
Each annual PPR describes a P&A
system’s activities, accomplishments
and expenditures to protect the rights of
individuals with mental illness
supported with payments from PAIMI
program allotments during the most
recently completed fiscal year. Each
P&A system transmit a copy of its
annual report to the Secretary (via
SAMHSA) and to the State Mental
Health Agency where the system is
located per the PAIMI Act at 42 U.S.C.
10824(a). Each annual PPR must
provide the Secretary with the following
information:
• The number of (PAIMI-eligible)
individuals with mental illness served;
• A description of the types of
activities undertaken;
• A description of the types of
facilities providing care or treatment to
which such activities are undertaken;
• A description of the manner in
which the activities are initiated;
• A description of the
accomplishments resulting from such
activities;
• A description of systems to protect
and advocate the rights of individuals
with mental illness supported with
payments from PAIMI program
allotments;
• A description of activities
conducted by states to protect and
advocate such rights;
• A description of mechanisms
established by residential facilities for
individuals with mental illness to
protect such rights;
• A description of the coordination
among such systems, activities, and
mechanisms;
• Specification of the number of
public and nonprofit P&A systems
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
established with PAIMI program
allotments; and
• Recommendations for activities and
services to improve the protection and
advocacy of the rights of individuals
with mental illness and a description of
the need for such activities and services
that were not met by the state P&A
systems established under the PAIMI
Act due to resource or annual program
priority limitations.
Each PAIMI grantee’s annual PPR
must include a separate section,
prepared by its PAIMI Advisory Council
(PAC), that describes the council’s
activities and its assessment of the state
P&A system’s operations per the PAIMI
Act at 42 U.S.C. 10805(7).
In 2017, SAMHSA included the
annual PAIMI PPR in the Web-based
Block Grant Application System
(WebBGAS). WebBGAS, SAMHSA’s
electronic data system, is used to collect
grantee information for the following
reasons:
(1) To meet the OMB requirements for
data collection for mandatory (formula)
grant programs;
(2) To comply with the annual
program reporting requirements of the
PAIMI Act, 42 U.S.C. 10801 et seq. and
the PAIMI Rules 42 CFR part 51;
(3) To simplify the submission of
PAIMI Program data by the state P&A
systems;
(4) To meet the Government
Performance and Results Act (GPRA)
requirements;
(5) To comply with the Government
Accountability Office (GAO) evaluation
recommendations that SAMHSA obtain
information that closely measures the
actual outcomes of the programs it
funds;
(6) To reduce the grantee data
collection burden by removing
information that did not facilitate
evaluation of a PAIMI grantee’s
programmatic and financial
management systems;
(7) To provide immediate access to
the PAIMI program data used to prepare
a section of the Secretary’s biennial
report to the President, Congress, and
National Council on Disability in
accordance with the Developmental
Disabilities Assistance Act of 2000 at 42
U.S.C. 15005. Reports of the Secretary;
(8) To improve SAMHSA’s ability to
create reports, analyze trends, and
provide timely feedback to the P&A
grantees when PPR revisions are
needed.
On July 17, 2017, OMB approved
SAMHSA’s PPR and Advisory Council
Report (Control No. 0930–0169,
Expiration Date July 31, 2020). The
burden estimate for the annual state
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 84, Number 112 (Tuesday, June 11, 2019)]
[Notices]
[Pages 27144-27146]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1112.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Opioid Drugs in Maintenance and Detoxification
Treatment of Opioid Dependence--42 CFR Part 8 (OMB No. 0930-0206) and
Opioid Treatment Programs (OTPs)--Extension
42 CFR part 8 establishes a certification program managed by
SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation
requires that Opioid Treatment Programs (OTPs) be certified.
``Certification'' is the process by which SAMHSA determines that an OTP
is qualified to provide opioid treatment under the Federal opioid
treatment standards established by the Secretary of Health and Human
Services. To become certified, an OTP must be accredited by a SAMHSA-
approved accreditation body. The regulation also provides standards for
such services as individualized treatment planning, increased medical
supervision, and assessment of patient outcomes. This submission seeks
continued approval of the information collection requirements in the
regulation and of the forms used in implementing the regulation.
SAMHSA currently has approval for the Application for Certification
to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 (Form SMA-
162); the Application for Approval as Accreditation Body Under 42 CFR
8.3(b) (Form SMA-163); and the Exception Request and Record of
Justification Under 42 CFR 8.12 (Form SMA-168), which may be used on a
voluntary basis by physicians when there is a patient care situation in
which the physician must make a treatment decision that differs from
the treatment regimen required by the regulation. Form SMA-168 is a
simplified, standardized form to facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the recordkeeping requirements in the
regulation are customary and usual practices within the medical and
rehabilitative communities and has not calculated a response burden for
them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and
8.12 include maintenance of the following: 5-year retention by
accreditation bodies of certain records pertaining to accreditation;
documentation by an OTP of the following: A patient's medical
examination when admitted to treatment, A patient's history, a
treatment plan, any prenatal support provided the patient,
justification of unusually large initial doses, changes in a patient's
dosage schedule, justification of unusually large daily doses, the
rationale for decreasing a patient's clinic attendance, and
documentation of physiologic dependence.
The rule also includes requirements that OTPs and accreditation
organizations disclose information. For example, 42 CFR 8.12(e)(1)
requires that a physician explain the facts concerning the use of
opioid drug treatment to each patient. This type of disclosure is
considered to be consistent with the common medical practice and is not
considered an additional burden. Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations shall make public their fee
structure; this type of disclosure is standard business practice and is
not considered a burden.
The tables that follow summarize the annual reporting burden
associated with the regulation, including burden associated with the
forms. There are no changes being made to the forms.
[[Page 27145]]
Estimated Annual Reporting Requirement Burden for Accreditation Bodies
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/
42 CFR citation Purpose respondents respondent responses response Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
8.3(b)(1-11).......................... Initial approval (SMA-163)...... 1 1 1 6.0 6
8.3(c)................................ Renewal of approval (SMA-163)... 2 1 2 1.0 2
8.3(e)................................ Relinquishment notification..... 1 1 1 0.5 0.5
8.3(f)(2)............................. Non-renewal notification to 1 90 90 0.1 9
accredited OTPs.
8.4(b)(1)(ii)......................... Notification to SAMHSA for 2 2 4 1.0 4
seriously noncompliant OTPs.
8.4(b)(1)(iii)........................ Notification to OTP for serious 2 10 20 1.0 20
noncompliance.
8.4(d)(1)............................. General documents and 6 5 30 0.5 15
information to SAMHSA upon
request.
8.4(d)(2)............................. Accreditation survey to SAMHSA 6 75 450 0.02 9
upon request.
8.4(d)(3)............................. List of surveys, surveyors to 6 6 36 0.2 7.2
SAMHSA upon request.
8.4(d)(4)............................. Report of less than full 6 5 30 0.5 15
accreditation to SAMHSA.
8.4(d)(5)............................. Summaries of Inspections........ 6 50 300 0.5 150
8.4(e)................................ Notifications of Complaints..... 12 6 72 0.5 36
8.6(a)(2) and (b)(3).................. Revocation notification to 1 185 185 0.3 55.5
Accredited OTPs.
8.6(b)................................ Submission of 90-day corrective 1 1 1 10 10.0
plan to SAMHSA.
8.6(b)(1)............................. Notification to accredited OTPs 1 185 185 0.3 55.0
of Probationary Status.
-------------------------------------------------------------------------------
Subtotal.......................... ................................ 54 .............. 1,407 .............. 394.20
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/
42 CFR citation Purpose respondents respondent responses response Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
8.11(b)............................... Renewal of approval (SMA-162)... 386 1 386 0.15 57.9
8.11(b)............................... Relocation of Program (SMA-162). 35 1 35 1.17 40.95
8.11(e)(1)............................ Application for provisional 42 1 42 1 42.00
certification.
8.11(e)(2)............................ Application for extension of 30 1 30 0.25 7.50
provisional certification.
8.11(f)(5)............................ Notification of sponsor or 60 1 60 0.1 6.00
medical director change (SMA-
162).
8.11(g)(2)............................ Documentation to SAMHSA for 1 1 1 1 1.00
interim maintenance.
8.11(h)............................... Request to SAMHSA for Exemption 1,200 20 24,000 0.07 1,680
from 8.11 and 8.12 (including
SMA-168).
8.11(i)(1)............................ Notification to SAMHSA Before 10 1 10 0.25 2.5
Establishing Medication Units
(SMA-162).
8.12(j)(2)............................ Notification to State Health 1 20 20 0.33 6.6
Officer When Patient Begins
Interim Maintenance.
8.24.................................. Contents of Appellant Request 2 1 2 0.25 .50
for Review of Suspension.
8.25(a)............................... Informal Review Request......... 2 1 2 1.00 2.00
8.26(a)............................... Appellant's Review File and 2 1 2 5.00 10.00
Written Statement.
8.28(a)............................... Appellant's Request for 2 1 2 1.00 2.00
Expedited Review.
8.28(c)............................... Appellant Review File and 2 1 2 5.00 10.00
Written Statement.
-------------------------------------------------------------------------------
Subtotal.......................... ................................ 1,775 .............. 24,594 .............. 1868.95
-------------------------------------------------------------------------------
Total......................... ................................ 1,829 .............. 26,001 .............. 2,263.15
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 27146]]
Send comments to Janet Heekin, SAMHSA Reports Clearance Officer,
Room 15E21-B, 5600 Fishers Lane, Rockville, MD 20850 OR email her a
copy at [email protected]. Written comments should be
received within 60 days of this notice.
Dated: June 6, 2019.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2019-12291 Filed 6-10-19; 8:45 am]
BILLING CODE 4162-20-P
